keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Experimental allergic encephalitogenic peptide (human), an EAE peptide, induces encephalomyelitis in guinea pigs [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Experimental allergic encephalitogenic peptide (human), an EAE peptide, induces encephalomyelitis in guinea pigs [1]. |
In vivo | The administration of an experimental allergic encephalitogenic peptide (human) at a dose of 30 μg via intracutaneous injection in conjunction with Freund's adjuvant triggers the onset of encephalomyelitis between days 9 and 19 post-injection in guinea pigs, with a mortality rate of 33% [1]. |
Molecular Weight | 1037.09 |
Formula | C46H64N14O14 |
CAS No. | 29705-92-8 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Experimental allergic encephalitogenic peptide (human) 29705-92-8 inhibitor inhibit